File Download

There are no files associated with this item.

Supplementary

Conference Paper: In vivo MRI detection of early ß-amyloid pathologies targeted by curcumin-conjugated magnetic nanoparticles

TitleIn vivo MRI detection of early ß-amyloid pathologies targeted by curcumin-conjugated magnetic nanoparticles
Authors
Issue Date2018
PublisherInternational Society for Magnetic Resonance in Medicine.
Citation
Proceedings of International Society for Magnetic Resonance in Medicine & The European Society for Magnetic Resonance in Medicine and Biology (ISMRM-ESMRMB) Joint Annual Meeting, Paris, France, 16-21 June 2018, abstract no. 1089 How to Cite?
AbstractEarly state β-amyloid oligomers (AβOs) and late stage Aβ plaques are the pathological hallmarks of Alzheimer's disease (AD) brains, and they can be targeted by curcumin. We have recently designed and synthesized a new curcumin-conjugated magnetic nanoparticles (Cur-MNPs) to target these Aβ pathologies. In this study, we aimed to assess this novel Cur-MNPs based MRI contrast agent for its in vivo ability to detect and visualize the Aβ pathologies during both very early and late stage of AD progression in AD mouse models.
DescriptionSpecial Session: Highlights of the Joint Annual Meeting ISMRM-ESMRMB - Oral Presentation -no. 1089
Persistent Identifierhttp://hdl.handle.net/10722/260714

 

DC FieldValueLanguage
dc.contributor.authorDong, CM-
dc.contributor.authorTo, KWA-
dc.contributor.authorWong, ECS-
dc.contributor.authorWu, EX-
dc.date.accessioned2018-09-14T08:46:12Z-
dc.date.available2018-09-14T08:46:12Z-
dc.date.issued2018-
dc.identifier.citationProceedings of International Society for Magnetic Resonance in Medicine & The European Society for Magnetic Resonance in Medicine and Biology (ISMRM-ESMRMB) Joint Annual Meeting, Paris, France, 16-21 June 2018, abstract no. 1089-
dc.identifier.urihttp://hdl.handle.net/10722/260714-
dc.descriptionSpecial Session: Highlights of the Joint Annual Meeting ISMRM-ESMRMB - Oral Presentation -no. 1089-
dc.description.abstractEarly state β-amyloid oligomers (AβOs) and late stage Aβ plaques are the pathological hallmarks of Alzheimer's disease (AD) brains, and they can be targeted by curcumin. We have recently designed and synthesized a new curcumin-conjugated magnetic nanoparticles (Cur-MNPs) to target these Aβ pathologies. In this study, we aimed to assess this novel Cur-MNPs based MRI contrast agent for its in vivo ability to detect and visualize the Aβ pathologies during both very early and late stage of AD progression in AD mouse models.-
dc.languageeng-
dc.publisherInternational Society for Magnetic Resonance in Medicine.-
dc.relation.ispartofISMRM-ESMRMB Joint Annual Meeting 2018-
dc.titleIn vivo MRI detection of early ß-amyloid pathologies targeted by curcumin-conjugated magnetic nanoparticles-
dc.typeConference_Paper-
dc.identifier.emailTo, KWA: toanthea@hku.hk-
dc.identifier.emailWu, EX: ewu@eee.hku.hk-
dc.identifier.authorityWu, EX=rp00193-
dc.identifier.hkuros291492-
dc.identifier.spageabstract no. 1089-
dc.identifier.epageabstract no. 1089-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats